Market revenue in 2022 | USD 78.2 million |
Market revenue in 2030 | USD 135.9 million |
Growth rate | 7.2% (CAGR from 2022 to 2030) |
Largest segment | Non-opioid |
Fastest growing segment | Compound Medication |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Opioid, Non-opioid, Compound Medication |
Key market players worldwide | Bayer AG, Assertio Holdings Inc, Johnson & Johnson, GSK PLC, AbbVie Inc, Novartis AG ADR, Viatris Inc, Teva Pharmaceutical Industries Ltd |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to analgesics market will help companies and investors design strategic landscapes.
Non-opioid was the largest segment with a revenue share of 51.92% in 2022. Horizon Databook has segmented the Kuwait analgesics market based on opioid, non-opioid, compound medication covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait analgesics market, including forecasts for subscribers. This country databook contains high-level insights into Kuwait analgesics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account